BridgeView Life Sciences is a technology and consulting firm specific to life sciences that provides services to help companies plan, launch, scale, and improve operations.

Selected to integrate the Government Contracts & Commercial Operations teams (39 FTEs) into a newly established Business Operations function, covering Trade & Distribution, Customer Operations, Insights & Solutions, Pricing & Contracts, Marketing Operations, Sales Training, and Sales Operations.• Restructured and resized the Business Operations team to adapt to evolving business needs with a focus on people and culture development.• Developed and executed strategic launch plans for NARCAN® OTC (~$500M revenue) into Retail, Public Interest and emerging B2B segments.• Led a cross-functional team (sales, supply chain, legal, etc.) to achieve strategic objectives for launching NARCAN® OTC and implementing changes to meet evolving market demands.

Chosen to merge the Government Procurement Contracts, R&D Contracts, and Proposals teams into a single Government Contract Operations Team (22 FTEs), ensuring contract excellence across all of Emergent's customer agreements.• Evaluated and restructured the team to align core competencies and establish consistent processes for all government contract engagements.• Introduced process improvements across Government Contracts, resulting in the delivery of over $500M in US and international revenue.• Directed the Integration Team during the $250M acquisition of Tembexa, integrating all functions of Emergent and managing the relationship with the divesting organization.

Led the Global Contract Operations Team (10 members) supporting the global sales of the Medical Countermeasure products to governments across the globe.• Development and implementation of the Procurement Order Process for International Government Agencies (Tenders, RFPs, RFIs, and RFQs)• Oversaw the fulfillment of Medical Countermeasure product sales exceeding $600M annually.• Launched and implemented Pricing Committee governance with oversight for the Commercial and Medical Counter Measure products.

Member of the Commercial Leadership Team and Strategic Business Partner, responsible for commercial operations, trade, market access, and patient services (Co-pay program, patient hub)• Presented commercial performance and emerging strategic initiatives to executive leadership and the board.• Responsible for developing and executing gross to net strategy for inline brands, including Authorized Generic Planning. • Realigned the sales force and revamped commercial data infrastructure to support the acquisition of inline products.• Onboarded a Patient Hub to enhance patient access, optimize payer coverage, and reduce distribution costs.

Led the Sales Operations, Forecasting, Commercial Analytics, and Trade & Distribution teams• Realigned the sales force, targeting, and incentive compensation to emphasize products with the highest growth and profitability potential.• Restructured the internal data warehouse and streamlined reporting.• Provided commercial assessments and advice to business development.

Commercial Lead for Grünenthal’s INTAC Technology, serving as the commercial representative for all North America Joint Steering Committees and collaborating with C-level executives and Sales and Marketing Leaders• Developed commercial assessments and business cases to support global and regional BD&L initiatives.• Led strategic marketing efforts, including all launch planning for pre-commercial assets.• Nominated into the ‘Development Program’ – Talent Pool.

Commercial Lead for the INTAC Technology Platform• Managed alliances with all partners in the US and Canada markets.• Developed comprehensive commercial support, including market research, competitive intelligence, and analytics.• Established all reporting systems and delivered monthly performance reviews to the Global Executive Team.